Innovate UK have put up £250,000 to get two Cambridge medical campuses serviced by driverless buses
PUBLISHED: 15:55 27 April 2017 | UPDATED: 16:00 27 April 2017
The £250K investment, co-funded by the UK’s innovation agency Innovate UK, will explore the business case for what could be a £3-£5 million driverless shuttle service.
Cambridge Biomedical Campus and the Wellcome Genome Campus have been picked out to test the autonomous shuttle service.
A consortium including the Wellcome Genome Campus, Cambridgeshire County Council (Smart Cambridge) and RDM Group, has won funding for a Cambridge Autonomous Bus System Feasibility Study as part of Innovate UK’s Connected and Autonomous Vehicles competition.
The feasibility study will also assess the wider business opportunity for utilising autonomous shuttles designed by RDM Group.
An out-of-hours driverless shuttle service on the fixed path from Trumpington Park and Ride will aim to allevieate congestion on the Cambridge Biomedical Campus.
Noelle Godfrey, Programme Director for the Connecting Cambridgeshire and Smart Cambridge programme, which is supported by the Greater Cambridge City Deal, said: “We welcome the success of our bid to Innovate UK for this collaborative project, which is testament to the power of local Councils, Universities and business working together in Greater Cambridge to find innovative solutions to improve the transport infrastructure. This project will complement Smart Cambridge’s on-going work with others to help transform the way people travel into, out of and around the city.”
The second area focuses on investigating a driverless shuttle service between the Wellcome Genome Campus and Whittlesford Parkway railway station, on a new off-road pathway.
The Wellcome Genome Campus is working to find a solution to the Campus’ challenge of how to easily connect its 2,600 workers from a wide catchment area to the local station, which is 2.9km away.
The Campus has experienced significant growth in employee numbers in recent years, and has a long-term expectation of doubling the number of workers over the next decade. Making it easier to travel to work by train is an important component of a sustainable transport strategy.
RDM will design and manufacture a larger version of its four and eight passenger self-driving pods to suit the location and customer needs. The new pods will be designed to accommodate wheelchairs, mobility scooters, and will carry bicycles in addition to seated passengers.
Martin Dougherty, Chief Operating Officer of the Wellcome Trust Sanger Institute and Wellcome Genome Campus said: “The Wellcome Genome Campus is not only a world-leading centre for genomic research, but it is also a green campus. We employ a wide range of high-tech solutions to minimise our impact on the environment. Exploring how driverless electric vehicles could provide our staff with easy access to the nearby rail station may offer opportunities to further minimise our carbon footprint.”
Wendy Arntsen, Head of Campus Development at the Wellcome Genome Campus, said: “It is very exciting to be part of this project and for the feasibility study to be recognised by Innovate UK as a cutting-edge technological solution for the traffic issues that many of us face. Our next steps will be to explore potential routes and design options for a new kind of pathway capable of combining travel by bike, on foot or by driverless vehicles. We will be consulting our neighbours on these possible routes and seeking their views as part of this feasibility study.”
Planning consent and funding for a new pathway are still to be explored. This feasibility study will be the first step in this project.